These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1689500)

  • 1. Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.
    Bourson A; Moser PC
    Psychopharmacology (Berl); 1990; 100(2):168-72. PubMed ID: 1689500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of dihydropyridine compounds in behavioural tests of dopaminergic activity.
    Bourson A; Gower AJ; Mir AK; Moser PC
    Br J Pharmacol; 1989 Dec; 98(4):1312-8. PubMed ID: 2482105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):34-7. PubMed ID: 3133698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of stress on drug-induced yawning: constant vs. intermittent stress.
    Tufik S; de Luca Nathan C; Neumann B; Hipólide DC; Lobo LL; de Medeiros R; Troncone LR; Braz S; Suchecki D
    Physiol Behav; 1995 Jul; 58(1):181-4. PubMed ID: 7667418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
    Yamada K; Furukawa T
    Psychopharmacology (Berl); 1980 Jan; 67(1):39-43. PubMed ID: 6768077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
    Ushijima I; Mizuki Y; Imaizumi J; Yamada M; Noda Y; Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):196-201. PubMed ID: 4004417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two inbred rat sublines that differ in spontaneous yawning behavior also differ in their responses to cholinergic and dopaminergic drugs.
    Urbá-Holmgren R; Santos A; Holmgren B; Eguíbar JR
    Behav Brain Res; 1993 Sep; 56(2):155-9. PubMed ID: 7902098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Age-related modification of dopaminergic-cholinergic neuronal interaction in rats].
    Kishimoto O
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):443-51. PubMed ID: 3250156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pre- and postoperative procedures on physostigmine- and apomorphine-induced yawning in rats.
    Bourson A; Moser PC
    Pharmacol Biochem Behav; 1989 Dec; 34(4):915-7. PubMed ID: 2623046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of cholinergic and dopaminergic influences on yawning behavior.
    Holmgren B; Urbá-Holmgren R
    Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yawning induced by apomorphine, physostigmine or pilocarpine is inhibited by electroconvulsive shock (ECS).
    Wielosz M; Szymczyk H
    Acta Physiol Hung; 1996; 84(4):473-5. PubMed ID: 9328636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atropine increases pilocarpine-induced yawning behavior in paradoxical sleep deprived rats.
    Lobo LL; de Medeiros R; Hipólide DC; Tufik S
    Pharmacol Biochem Behav; 1995 Nov; 52(3):485-8. PubMed ID: 8545463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.
    Zarrindast MR; Jamshidzadeh A
    Br J Pharmacol; 1992 Mar; 105(3):675-8. PubMed ID: 1385751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of voltage dependent calcium channels and cholinergic receptors in the convulsant action of BAY k-8644.
    Wielosz M; Młynarczyk M; Kleinrok Z
    Pol J Pharmacol; 1997; 49(5):369-71. PubMed ID: 9566038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute or chronic effects of cannabinoids on spontaneous or pharmacologically induced yawning in rats.
    Nakamura-Palacios EM; Amodeo Bueno OF; Takahashi RN; Tufik S
    Pharmacol Biochem Behav; 2002 Dec; 74(1):205-12. PubMed ID: 12376169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions.
    O'Neill SK; Bolger GT
    Brain Res Bull; 1990 Jul; 25(1):211-4. PubMed ID: 1698518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dihydropyridine Ca2+ channel blockers on the discriminative stimulus and the motor impairing effects of (+/-)-Bay K 8644.
    Cohen C; Perrault G; Sanger DJ
    Eur J Pharmacol; 1997 Oct; 336(2-3):113-21. PubMed ID: 9384222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.